• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对流感蛋白的保护性抗体。

Protective Antibodies Against Influenza Proteins.

机构信息

LIV, Facultad de Medicina, Universidad Autonoma del Estado de Morelos, Cuernavaca, Mexico.

Instituto de Biotecnologia, Universidad Nacional Autonoma de Mexico, Cuernavaca, Mexico.

出版信息

Front Immunol. 2019 Jul 18;10:1677. doi: 10.3389/fimmu.2019.01677. eCollection 2019.

DOI:10.3389/fimmu.2019.01677
PMID:31379866
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6657620/
Abstract

The influenza A virus infection continues to be a threat to the human population. The seasonal variation of the virus and the likelihood of periodical pandemics caused by completely new virus strains make it difficult to produce vaccines that efficiently protect against this infection. Antibodies (Abs) are very important in preventing the infection and in blocking virus propagation once the infection has taken place. However, the precise protection mechanism provided by these Abs still needs to be established. Furthermore, most research has focused on Abs directed to the globular head domain of hemagglutinin (HA). However, other domains of HA (like the stem) and other proteins are also able to elicit protective Ab responses. In this article, we review the current knowledge about the role of both neutralizing and non-neutralizing anti-influenza proteins Abs that play a protective role during infection or vaccination.

摘要

甲型流感病毒感染仍然是人类的威胁。病毒的季节性变化以及完全新型病毒株引发周期性大流行的可能性,使得生产有效预防这种感染的疫苗变得困难。抗体(Abs)在预防感染和阻止感染发生后病毒传播方面非常重要。然而,这些 Abs 提供的确切保护机制仍有待确定。此外,大多数研究都集中在针对血凝素(HA)球形头部结构域的 Abs 上。然而,HA 的其他结构域(如茎部)和其他蛋白质也能够引发保护性 Abs 反应。在本文中,我们综述了目前关于中和性和非中和性抗流感蛋白 Abs 在感染或接种疫苗期间发挥保护作用的认识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2258/6657620/7dbb070778cc/fimmu-10-01677-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2258/6657620/7dbb070778cc/fimmu-10-01677-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2258/6657620/7dbb070778cc/fimmu-10-01677-g0001.jpg

相似文献

1
Protective Antibodies Against Influenza Proteins.针对流感蛋白的保护性抗体。
Front Immunol. 2019 Jul 18;10:1677. doi: 10.3389/fimmu.2019.01677. eCollection 2019.
2
Eliciting broadly protective antibody responses against influenza.诱导针对流感的广泛保护性抗体反应。
Curr Opin Immunol. 2014 Jun;28:71-6. doi: 10.1016/j.coi.2014.02.005. Epub 2014 Mar 12.
3
Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones.广泛中和抗流感病毒抗体:多克隆混合物及IgA骨架中中和效力的增强
J Virol. 2015 Apr;89(7):3610-8. doi: 10.1128/JVI.03099-14. Epub 2015 Jan 14.
4
Conformational Stability of the Hemagglutinin of H5N1 Influenza A Viruses Influences Susceptibility to Broadly Neutralizing Stem Antibodies.H5N1 流感病毒血凝素的构象稳定性影响对广谱中和茎部抗体的敏感性。
J Virol. 2018 May 29;92(12). doi: 10.1128/JVI.00247-18. Print 2018 Jun 15.
5
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines.流感 B 细胞保护性表位的鉴定:合理设计新型广谱抗流感疫苗的关键。
Viruses. 2012 Nov 14;4(11):3090-108. doi: 10.3390/v4113090.
6
H5N1 Vaccine-Elicited Memory B Cells Are Genetically Constrained by the IGHV Locus in the Recognition of a Neutralizing Epitope in the Hemagglutinin Stem.H5N1疫苗引发的记忆B细胞在识别血凝素茎中的中和表位时受到IGHV基因座的遗传限制。
J Immunol. 2015 Jul 15;195(2):602-10. doi: 10.4049/jimmunol.1402835. Epub 2015 Jun 15.
7
Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?头部、茎部以及其他一切:抗体如何根除作为人类疾病的流感?
Curr Opin Immunol. 2016 Oct;42:48-55. doi: 10.1016/j.coi.2016.05.012. Epub 2016 Jun 3.
8
Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.在对历史 H3N2 流感病毒无预存免疫的雪貂中引发针对未来 20 年 H3N2 共循环流感病毒变异株的保护性抗体。
J Virol. 2019 Jan 17;93(3). doi: 10.1128/JVI.00946-18. Print 2019 Feb 1.
9
Novel Platforms for the Development of a Universal Influenza Vaccine.新型平台助力通用型流感疫苗研发。
Front Immunol. 2018 Mar 23;9:600. doi: 10.3389/fimmu.2018.00600. eCollection 2018.
10
Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses.合成的Toll样受体4(TLR4)和TLR7配体作为流感病毒疫苗佐剂可诱导快速、持久且具有广泛保护性的反应。
J Virol. 2015 Mar;89(6):3221-35. doi: 10.1128/JVI.03337-14. Epub 2015 Jan 7.

引用本文的文献

1
T Cell Responses to Influenza Infections in Cattle.牛对流感感染的T细胞反应。
Viruses. 2025 Aug 14;17(8):1116. doi: 10.3390/v17081116.
2
Dose-sparing effects of novel adjuvants and aluminum hydroxide on two different vaccines in a neonatal mouse model.新型佐剂和氢氧化铝在新生小鼠模型中对两种不同疫苗的剂量节省效应。
Front Immunol. 2025 Jul 31;16:1646677. doi: 10.3389/fimmu.2025.1646677. eCollection 2025.
3
Inflammatory conditions shape phenotypic and functional characteristics of lung-resident memory T cells in mice.炎症状态塑造了小鼠肺驻留记忆T细胞的表型和功能特征。

本文引用的文献

1
Antibody Responses toward the Major Antigenic Sites of Influenza B Virus Hemagglutinin in Mice, Ferrets, and Humans.针对乙型流感病毒血凝素主要抗原表位的抗体反应在小鼠、雪貂和人类中。
J Virol. 2019 Jan 4;93(2). doi: 10.1128/JVI.01673-18. Print 2019 Jan 15.
2
Antigenic sites in influenza H1 hemagglutinin display species-specific immunodominance.流感 H1 血凝素中的抗原表位呈现出物种特异性的免疫优势。
J Clin Invest. 2018 Nov 1;128(11):4992-4996. doi: 10.1172/JCI122895. Epub 2018 Oct 8.
3
Immunodominance of Antigenic Site B in the Hemagglutinin of the Current H3N2 Influenza Virus in Humans and Mice.
Nat Commun. 2025 Apr 16;16(1):3612. doi: 10.1038/s41467-025-58931-y.
4
Induction of enhanced stem-directed neutralizing antibodies by HA2-16 ferritin nanoparticles with H3 influenza virus boost.通过带有H3流感病毒加强剂的HA2-16铁蛋白纳米颗粒诱导增强的茎部导向中和抗体。
Nanoscale Adv. 2025 Feb 11;7(7):2011-2020. doi: 10.1039/d4na00964a. eCollection 2025 Mar 25.
5
Designing a multi-epitope influenza vaccine: an immunoinformatics approach.设计多表位流感疫苗:一种免疫信息学方法。
Sci Rep. 2024 Oct 25;14(1):25382. doi: 10.1038/s41598-024-74438-w.
6
Evaluation of the Effect of Influenza Vaccine on the Development of Symptoms in SARS-CoV-2 Infection and Outcome in Patients Hospitalized due to COVID-19.评估流感疫苗对SARS-CoV-2感染症状发展及因COVID-19住院患者预后的影响。
Vaccines (Basel). 2024 Jul 12;12(7):765. doi: 10.3390/vaccines12070765.
7
Polyanhydride nanovaccine against H3N2 influenza A virus generates mucosal resident and systemic immunity promoting protection.抗甲型H3N2流感病毒的聚酸酐纳米疫苗可产生黏膜驻留免疫和全身免疫,增强保护作用。
NPJ Vaccines. 2024 May 31;9(1):96. doi: 10.1038/s41541-024-00883-3.
8
Global Prevalence and Hemagglutinin Evolution of H7N9 Avian Influenza Viruses from 2013 to 2022.2013 年至 2022 年 H7N9 禽流感病毒的全球流行情况和血凝素进化。
Viruses. 2023 Nov 4;15(11):2214. doi: 10.3390/v15112214.
9
Rapid, high throughput, automated detection of SARS-CoV-2 neutralizing antibodies against Wuhan-WT, delta and omicron BA1, BA2 spike trimers.针对武汉野生型、德尔塔和奥密克戎BA1、BA2刺突三聚体的SARS-CoV-2中和抗体的快速、高通量、自动化检测。
iScience. 2023 Oct 18;26(11):108256. doi: 10.1016/j.isci.2023.108256. eCollection 2023 Nov 17.
10
Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza A viruses.鉴定针对甲型流感病毒 M1 和 NP 的非中和性人源单克隆抗体。
J Virol. 2023 Nov 30;97(11):e0164622. doi: 10.1128/jvi.01646-22. Epub 2023 Nov 2.
抗原表位 B 在当前 H3N2 流感病毒血凝素中的免疫优势在人类和小鼠中。
J Virol. 2018 Sep 26;92(20). doi: 10.1128/JVI.01100-18. Print 2018 Oct 15.
4
Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies.人类流感感染诱导广泛交叉反应和保护性神经氨酸酶反应性抗体。
Cell. 2018 Apr 5;173(2):417-429.e10. doi: 10.1016/j.cell.2018.03.030.
5
NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?神经氨酸酶为基础的免疫作用如何能有助于更好的流感病毒疫苗?
mBio. 2018 Apr 3;9(2):e02332-17. doi: 10.1128/mBio.02332-17.
6
Immunomodulatory Nonstructural Proteins of Influenza A Viruses.甲型流感病毒的免疫调节非结构蛋白。
Trends Microbiol. 2018 Jul;26(7):624-636. doi: 10.1016/j.tim.2017.12.006. Epub 2018 Jan 17.
7
Roles of antibodies to influenza A virus hemagglutinin, neuraminidase, and M2e in conferring cross protection.甲型流感病毒血凝素、神经氨酸酶及基质蛋白2外显子抗体在提供交叉保护中的作用。
Biochem Biophys Res Commun. 2017 Nov 4;493(1):393-398. doi: 10.1016/j.bbrc.2017.09.011. Epub 2017 Sep 5.
8
Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin.采用酶联免疫吸附测定法(ELISA)和酶抑制法分析儿童、成人及老年人中抗流感病毒神经氨酸酶抗体:抗原原罪的证据
mBio. 2017 Mar 21;8(2):e02281-16. doi: 10.1128/mBio.02281-16.
9
A Broadly Reactive Human Anti-hemagglutinin Stem Monoclonal Antibody That Inhibits Influenza A Virus Particle Release.一种广谱反应性人抗血凝素茎单克隆抗体,可抑制甲型流感病毒粒子释放。
EBioMedicine. 2017 Mar;17:182-191. doi: 10.1016/j.ebiom.2017.03.007. Epub 2017 Mar 6.
10
Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins.定义针对流感病毒表面糖蛋白的抗体交叉反应组。
Nat Immunol. 2017 Apr;18(4):464-473. doi: 10.1038/ni.3684. Epub 2017 Feb 13.